Very thin buy side, it wouldn't take much to sell this down into the low 20s. The corollary: sell side not quite as thin, but pretty lean too. Wouldn't take much to buy this up to the mid 30s. Time will tell...
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game